MedTrace Logo

Detection Rate of Liver Metastases With Contrast Enhanced Intraoperative Ultrasound Compared to Regular Imaging

NCT01522209 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 59

Last updated 2015-01-15

No results posted yet for this study

Summary

The study compares the established imaging techniques (CT, MRT, Contrast Ultrasound) with the new method of intraoperative contrast enhanced ultrasound to compare all methods for their rate of detection of colorectal liver metastasis.

Conditions

  • Colon Cancer Liver Metastasis
  • Contrast Enhances Intraoperative Ultrasound
  • Imaging for Liver Cancer
  • Imaging for Liver Metastasis

Interventions

PROCEDURE

Liver Surgery

R0 Resection of Liver Metastases after Planning with preoperative imaging data and comparison with intraoperative contrast enhanced ultrasound

DEVICE

Contrast Enhanced Ultrasound

The contrast enhanced Ultrasound imaging is performed before and during the operation using Sonovue contrast agent (2.5ml iv preop, 4.5ml iv intraop)

RADIATION

CT Scan (standard)

A staging CT of the liver/abdomen with the minimal possible dosage for aquiring sufficent triphasic data in a 64-line helical scan

RADIATION

Primovist MRI (3 Tesla)

an MRI scan of the liver with Primovist contrast agent including late phase as addition to the preop staging according to the protocol

Sponsors & Collaborators

  • Asklepios Kliniken Hamburg GmbH

    lead OTHER

Principal Investigators

  • Gregor A Stavrou, Dr.med · Dpt. of General and Visceral Surgery, Asklepios Hospital Barmbek, Hamburg, Germany

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2014-12-31
Completion
2015-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01522209 on ClinicalTrials.gov